• Tidak ada hasil yang ditemukan

Motilal Oswal Midcap Fund

N/A
N/A
Protected

Academic year: 2024

Membagikan "Motilal Oswal Midcap Fund"

Copied!
1
0
0

Teks penuh

(1)

Motilal Oswal Midcap Fund CRISIL MF RANK - 1

Mid Cap Fund Dec 2022

Key Highlights Investment Objective Ratios^

Inception Date 24-Feb-14 Portfolio Beta 0.84

Benchmark Nifty Midcap 150

Index TRI R Squared (%) 81.62

Avg. AUM in Rs. Cr

(Oct - Dec 2022) 3,586 Standard Deviation (%) 33.18

Fund Manager Niket Shah,

Ankush Sood Key Portfolio Attributes Sharpe Ratio 1.32

Expense Ratio (%) 2.04 NAV as on 30/12/2022 50.56 Treynor Ratio 0.35

Exit Load (%) 1.00 No. of Holdings 32 Jenson's Alpha (%) 5.93

Min. Investment (Rs.) 500 Top 5 Company Exposure (%) 42.54 Sortino Ratio 0.79

Top 5 Sector Exposure (%) 46.21 ^ratios are annualized; for a period of 3 years

Trailing Point to Point Returns (%) Fund Benchmark

1 year 10.71 3.91 Period 3 years 5 years 10 years

3 years 23.55 24.57 Amt. Invested 36,000 60,000 84,000

5 years 12.54 11.18 Scheme Value (Rs) 53,674 102,107 NA

10 years NA 17.38 Returns (%) 30.79 22.50 NA

Inception 20.09 20.56 Benchmark Value (Rs) 50,308 96,880 303,167

Returns (%) 25.82 20.29 17.95

Market Cap Trend (% & rebased to 100)

YTD -5.87 ## -5.27

2019 14.20 ## 12.18

2018 -2.11 ## -1.24

2017 29.18 ## 31.49

Top 10 Company Holdings (%)

History Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21

CRISIL Mutual Fund Rank 1 1 2 3 3 5 5

AUM (Rs. Cr.) 3,586 3,046 2,615 2,611 2,513 2,195 1,940

All data as on December 30, 2022

Top 10 Sector Holdings (%)

Disclaimer: CRISIL Research, a division of CRISIL Limited (CRISIL) has taken due care and caution in preparing this Report based on the information obtained by CRISIL from sources which it considers reliable (Data). However, CRISIL does not guarantee the accuracy, adequacy or completeness of the Data / Report and is not responsible for any errors or omissions or for the results obtained from the use of Data / Report. This Report is not a recommendation to invest / disinvest in any entity covered in the Report and no part of this report should be construed as an investment advice. CRISIL especially states that it has no financial liability whatsoever to the subscribers/ users/ transmitters/ distributors of this Report. CRISIL Research operates independently of, and does not have access to information obtained byCRISIL’s Ratings Division / CRISIL Risk and Infrastructure Solutions Limited (CRIS), which may, in their regular operations, obtain information of a confidential nature. The views expressed in this Report are that of CRISIL Research and not of CRISIL’s Ratings Division / CRIS. No part of this Report may be published / reproduced in any form without CRISIL’s prior written approval.

Fund v/s benchmark performance (growth of 1000 since inception) To achieve long term capital appreciation by investing in a

maximum of 30 quality midcap companies having long- term competitive advantages and potential for growth.

SIP Performance (based on monthly investment of Rs 1000)

For less than 1 year absolute and for more than 1 year annualised

10.62 10.49 10.33

6.27 4.83 4.11 3.74 3.09 3.07 2.87

0.00 4.00 8.00 12.00 16.00 20.00

CG Power & Indl Solns Ltd. Phoenix Mills Ltd. Tube Investments Of India Ltd. Campus Activewear Ltd. Ambuja Cements Ltd. Max Fin. Services Gujarat Gas Voltas Ltd. Au Small Fin. Bank Deepak Nitrite Ltd.

11.17 10.62 10.33

7.82

6.27 5.23

4.06 3.93 3.74 3.16

0.00 2.00 4.00 6.00 8.00 10.00 12.00

Residential/Comm. /SEZ Power Equipment Auto Ancillaries NBFC Footwear Cement Chemicals - Speciality Retailing Gas Trans./Mktg. Hospital

500 1500 2500 3500 4500 5500 6500

Feb-14 Nov-14 Aug-15 May-16 Jan-17 Oct-17 Jul-18 Apr-19 Jan-20 Oct-20 Jun-21 Mar-22 Dec-22

Motilal Oswal Midcap Fund - Growth Nifty Midcap 150 Index TRI 0.00

10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00

Jan-20 Jun-20 Nov-20 Apr-21 Sep-21 Feb-22 Jul-22 Dec-22

Large Cap Mid Cap Small Cap

Referensi

Dokumen terkait

For further information on CRISIL's privacy policy please visit www.crisil.com Disclaimer CRISIL Research, a division of CRISIL Limited CRISIL has taken reasonable care and caution

Rating Rationale August 18, 2021 | Mumbai Maja Health Care Division Ratings reaffirmed at 'CRISIL BBB / Stable / CRISIL A3+ ' Rating Action Total Bank Loan Facilities Rated Rs.17.5

Rating Rationale March 27, 2018 | Mumbai Haldia Nirman Projects Private Limited Ratings migrated to 'CRISIL B/Stable/CRISIL A4' Rating Action Total Bank Loan Facilities Rated Rs.10

Rating Rationale January 05, 2022 | Mumbai Apex Frozen Foods Limited Ratings reaffirmed at 'CRISIL A- / Stable / CRISIL A2+ '; rated amount enhanced for Bank Debt Rating Action

Rating Rationale July 05, 2021 | Mumbai Sangrur Agro Limited Ratings reaffirmed at 'CRISIL BBB+ / Stable / CRISIL A2 '; rated amount enhanced for Bank Debt Rating Action Total Bank

Rating Rationale July 08, 2021 | Mumbai Meenakshi Polymers Private Limited Ratings downgraded to 'CRISIL BB+/Stable/CRISIL A4+’ Rating Action Total Bank Loan Facilities Rated Rs.40

Rating Rationale January 05, 2022 | Mumbai SPS Steels Rolling Mills Limited Ratings upgraded to 'CRISIL BBB+ / Stable / CRISIL A2 '; rated amount enhanced for Bank Debt Rating

You can view the Company’s Customer Privacy at https://www.spglobal.com/privacy Last updated: April 2016 Disclaimer CRISIL Research, a division of CRISIL Limited CRISIL has taken